Newtree Co., Ltd. (KOSDAQ:270870)
South Korea · Delayed Price · Currency is KRW 5,910.00
-30.00 (-0.51%)
At close: Aug 7, 2025, 3:30 PM KST
Revance Therapeutics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2020 |
Operating Revenue | 104,792 | 111,558 | 137,828 | 182,077 | 243,529 | 187,182 | Upgrade |
Other Revenue | 6,044 | 10,415 | 13,550 | 3,209 | 3,428 | 2,217 | Upgrade |
| 110,836 | 121,973 | 151,377 | 185,286 | 246,958 | 189,399 | Upgrade | |
Revenue Growth (YoY) | -23.72% | -19.43% | -18.30% | -24.97% | 30.39% | 51.34% | Upgrade |
Cost of Revenue | 27,487 | 27,921 | 32,240 | 43,881 | 54,468 | 41,445 | Upgrade |
Gross Profit | 83,349 | 94,052 | 119,137 | 141,405 | 192,490 | 147,953 | Upgrade |
Selling, General & Admin | 80,427 | 85,435 | 105,529 | 133,460 | 166,526 | 121,532 | Upgrade |
Research & Development | 2,200 | 1,884 | 1,199 | 1,046 | 2,484 | 1,035 | Upgrade |
Operating Expenses | 84,386 | 89,119 | 108,953 | 136,966 | 171,342 | 125,097 | Upgrade |
Operating Income | -1,037 | 4,933 | 10,184 | 4,439 | 21,148 | 22,857 | Upgrade |
Interest Expense | -261.22 | -235.84 | -503.14 | -1,236 | -621.02 | -227.01 | Upgrade |
Interest & Investment Income | 798.15 | 857.46 | 1,002 | 1,231 | 407.73 | 321.24 | Upgrade |
Currency Exchange Gain (Loss) | -42.23 | 25.88 | -124.63 | 430.29 | 49.36 | 25.13 | Upgrade |
Other Non Operating Income (Expenses) | 519.88 | -1,729 | -4,450 | 765.52 | -4.52 | -143.27 | Upgrade |
EBT Excluding Unusual Items | -22.87 | 3,851 | 6,108 | 5,629 | 20,979 | 22,833 | Upgrade |
Gain (Loss) on Sale of Investments | 541.83 | 644.95 | 1,189 | -117.2 | 1,402 | 562.78 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -4.45 | 766.41 | 1,136 | -358.1 | Upgrade |
Other Unusual Items | - | - | -1,682 | - | - | - | Upgrade |
Pretax Income | 518.96 | 4,496 | 5,611 | 6,278 | 23,518 | 23,037 | Upgrade |
Income Tax Expense | -769.58 | -199.76 | 1,472 | 1,456 | 4,337 | 4,279 | Upgrade |
Earnings From Continuing Operations | 1,289 | 4,696 | 4,139 | 4,822 | 19,180 | 18,759 | Upgrade |
Earnings From Discontinued Operations | - | - | 526.93 | -70.71 | 705.55 | 661.2 | Upgrade |
Net Income to Company | 1,289 | 4,696 | 4,666 | 4,751 | 19,886 | 19,420 | Upgrade |
Minority Interest in Earnings | 71.32 | 111.11 | -56.2 | -8.04 | -193.62 | -238.37 | Upgrade |
Net Income | 1,360 | 4,807 | 4,609 | 4,743 | 19,692 | 19,182 | Upgrade |
Net Income to Common | 1,360 | 4,807 | 4,609 | 4,743 | 19,692 | 19,182 | Upgrade |
Net Income Growth | -85.02% | 4.29% | -2.83% | -75.91% | 2.66% | 101.06% | Upgrade |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade |
Shares Change (YoY) | -0.11% | - | 0.15% | -0.68% | 1.15% | -2.04% | Upgrade |
EPS (Basic) | 151.22 | 534.41 | 512.44 | 528.11 | 2234.70 | 2168.17 | Upgrade |
EPS (Diluted) | 150.97 | 534.00 | 512.44 | 528.11 | 2193.99 | 2144.95 | Upgrade |
EPS Growth | -85.02% | 4.21% | -2.97% | -75.93% | 2.29% | 104.72% | Upgrade |
Free Cash Flow | 16,456 | 4,750 | 7,875 | -11,092 | 10,062 | -13,629 | Upgrade |
Free Cash Flow Per Share | 1830.03 | 528.06 | 875.55 | -1235.00 | 1112.65 | -1524.31 | Upgrade |
Dividend Per Share | - | - | 250.000 | 250.000 | 250.000 | 250.000 | Upgrade |
Dividend Growth | - | - | - | - | - | 66.67% | Upgrade |
Gross Margin | 75.20% | 77.11% | 78.70% | 76.32% | 77.94% | 78.12% | Upgrade |
Operating Margin | -0.94% | 4.04% | 6.73% | 2.40% | 8.56% | 12.07% | Upgrade |
Profit Margin | 1.23% | 3.94% | 3.04% | 2.56% | 7.97% | 10.13% | Upgrade |
Free Cash Flow Margin | 14.85% | 3.89% | 5.20% | -5.99% | 4.07% | -7.20% | Upgrade |
EBITDA | 800.33 | 6,809 | 12,163 | 6,753 | 23,351 | 24,755 | Upgrade |
EBITDA Margin | 0.72% | 5.58% | 8.04% | 3.64% | 9.46% | 13.07% | Upgrade |
D&A For EBITDA | 1,838 | 1,876 | 1,980 | 2,314 | 2,203 | 1,898 | Upgrade |
EBIT | -1,037 | 4,933 | 10,184 | 4,439 | 21,148 | 22,857 | Upgrade |
EBIT Margin | -0.94% | 4.04% | 6.73% | 2.40% | 8.56% | 12.07% | Upgrade |
Effective Tax Rate | - | - | 26.24% | 23.20% | 18.44% | 18.57% | Upgrade |
Advertising Expenses | - | 32,702 | 36,391 | 48,391 | 55,161 | 39,682 | Upgrade |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.